.svg)
Flagging Microbes That Are Crowding Out the Rest
The overabundant species test pinpoints bacterial and fungal groups with unusually high relative abundance. Results highlight “who’s too loud in the room,” flagging species or genera that dominate beyond typical reference ranges for a healthy, diverse gut community. Because microbiomes evolve with diet, medications, and stress, this test reflects your current ecosystem rather than a fixed trait.
Why Dominance Matters More Than Any One Species
Why this matters: your gut microbes help digest fiber into short-chain fatty acids, shape immune tone, train the gut barrier, and even influence metabolic and mood signaling through the gut–brain axis. When one or a few taxa swell beyond their neighbors, functions can skew — think excess gas production, altered bile acid recycling, or more inflammatory signaling. While the science continues to mature, consistent patterns emerge: more diversity is generally linked with resilience, and dominance by a narrow cast of microbes often tracks with symptoms or instability.
Day to day, your microbiome is like a city that runs on shared jobs. Different microbial “neighborhoods” ferment fiber, produce vitamins, reinforce the mucus barrier, and break down bile. When one group grows outsized, it can crowd out helpful neighbors and tilt the city’s economy. The overabundant species test connects that biology to real-life questions: Why the sudden bloating after antibiotics? Could your recent ultra-processed stretch be feeding gas-producing microbes? Are you seeing more skin flares or food-triggered discomfort after a restrictive diet? By mapping relative abundance against reference populations, the test helps identify dysbiosis patterns that can accompany digestive symptoms, immune reactivity, and metabolic shifts.
When to Reach for This View of the Microbiome
It’s particularly useful after big inflection points — a course of antibiotics, a major diet change, new supplements, travel, a GI infection, or persistent symptoms that haven’t resolved. Overabundance of certain pathobionts (microbes that can be friendly in moderation but problematic in excess) may point to lower short-chain fatty acid output, higher histamine or lipopolysaccharide exposure, or reduced butyrate producers that support the gut barrier. For context, larger cohort studies associate higher microbial diversity with metabolic flexibility and lower inflammatory tone, though specifics vary and ongoing research is refining the details. This test won’t diagnose disease and it won’t locate small-intestinal overgrowth directly (stool reflects the colon, and breath testing assesses the small intestine). It’s a snapshot, based on relative — not absolute — counts, and results can differ across labs because of sequencing methods and databases. Used alongside your history and other biomarkers, it becomes a practical compass rather than a verdict.
Reading a Dominance Report
Your report shows which species or genera are disproportionately high compared with reference ranges. It typically summarizes relative abundance, diversity metrics, and functional clues — for example, whether gas producers or mucin degraders occupy more space than is typical for a stable gut community. “Balanced” profiles tend to feature higher diversity and healthy representation of beneficial genera like Bifidobacterium and Faecalibacterium.
When the ecosystem is balanced, you’re more likely to see efficient fiber fermentation with robust short-chain fatty acid production (butyrate, acetate, propionate), steadier immune signaling, and a well-supported gut barrier. Optimal patterns vary by person, geography, and diet, but stability and diversity are the recurring themes.
When imbalance appears, you may see lower diversity with one or a few taxa dominating. That pattern can align with symptoms such as gas, urgency, constipation, or food-triggered discomfort, or with an ecosystem recovering from antibiotics or infection. These findings aren’t a diagnosis — they’re functional signposts that can inform nutrition strategies, prebiotic discussions, or medical evaluation if symptoms persist.
Where an Overabundant Species Test Helps — and Where It Doesn't
Big picture, this test is most informative when viewed over time and alongside other markers such as fecal calprotectin (gut inflammation), serum metabolic labs, or immune panels. Keep in mind that recent antibiotics, colonoscopy prep, probiotics, and acute illness can shift results; collection variability and lab methods also influence readouts. Interpreted in context, the overabundant species test helps personalize your path toward steadier digestion, energy, and resilience.
FAQs
The Overabundant Species Test analyzes the genetic material of bacteria, fungi, and other microorganisms in stool to identify which species are present, their relative abundance, overall species diversity, and inferred functional potential (for example, metabolic capabilities or gene functions suggested by detected sequences).
Results describe microbial balance—highlighting species that are overrepresented or underrepresented and potential shifts in microbial function—but they do not by themselves diagnose disease; clinical interpretation requires correlation with symptoms, history, and other laboratory or medical assessments.
The overabundant species test is a simple at‑home stool collection using the small swab or vial provided in your kit; you collect a small sample following the kit directions (usually swabbing a fresh stool surface or placing a small amount into the vial), then securely cap the container.
Maintain cleanliness—wash hands before and after, avoid touching the swab tip or rim of the vial, and prevent cross‑contamination—clearly label the sample with your name/ID and date, and follow the kit’s instructions for sample amount, storage, and prompt return; proper collection, labeling, and adherence to instructions are essential for accurate sequencing results.
Overabundant Species Test results can reveal insights about digestion, inflammation, nutrient absorption, metabolism, and gut–brain communication. By identifying which microbial species are present at higher-than-expected levels, the report can suggest how those imbalances might affect stool transit and digestion, inflammatory signaling in the gut, the availability and synthesis of certain vitamins and nutrients, metabolic activities like short‑chain fatty acid production, and microbial pathways that interact with the nervous system.
However, microbiome patterns can correlate with, but don’t diagnose, specific health conditions — they are one piece of the clinical picture. Results are most useful when interpreted alongside symptoms, standard laboratory tests, and a healthcare professional’s assessment to determine whether dietary changes, targeted supplements or further medical evaluation are warranted.
Next‑generation sequencing provides high‑resolution microbial data—allowing detection and relative quantification of many species—but interpretation of Overabundant Species Test results is probabilistic: outputs are statistical estimates influenced by sequencing depth, sample handling, reference databases and bioinformatics pipelines, so results indicate likelihoods or relative shifts rather than absolute certainties.
Results represent a snapshot in time and can change with recent diet, stress, illness or antibiotic use, as well as sampling variability; for this reason single measurements should be interpreted in clinical or experimental context and, when needed, confirmed with repeat sampling or complementary tests.
Many people test their overabundant species once per year to establish a baseline, but if you’re actively changing diet, starting probiotics, or using other interventions it’s common to test every 3–6 months to monitor response and guide adjustments.
Focus on comparing trends over time rather than a one-off reading — serial tests reveal direction, magnitude, and persistence of change and help distinguish short-term variability from meaningful shifts.
Yes — microbial populations, including overabundant species, can shift rapidly: some taxa respond within days to dietary or lifestyle changes, producing measurable but sometimes transient changes in community composition.
However, more stable patterns generally emerge over weeks to months, so maintain consistent diet and lifestyle for several weeks before retesting to ensure comparisons reflect persistent change rather than short-term fluctuation.
References
- Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., Tito, R. Y., Chaffron, S., Rymenans, L., Verspecht, C., De Sutter, L., Lima-Mendez, G., D'hoe, K., Jonckheere, K., Homola, D., & Raes, J. (2016). Population-level analysis of gut microbiome variation. Science, 352(6285), 560-564. https://doi.org/10.1126/science.aad3503
- Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001. https://doi.org/10.3389/fmicb.2022.999001
- Fusco, W., Lorenzo, M. B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M. C., Gasbarrini, A., Collado, M. C., Cammarota, G., & Ianiro, G. (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. Nutrients, 15(9), 2211. https://doi.org/10.3390/nu15092211
- Jovel, J., Patterson, J., Wang, W., Hotte, N., O'Keefe, S., Mitchel, T., Perry, T., Kao, D., Mason, A. L., Madsen, K. L., & Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. Frontiers in Microbiology, 7, 459. https://doi.org/10.3389/fmicb.2016.00459
- Drago, L. (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. Frontiers in Microbiology, 16, 1580531. https://doi.org/10.3389/fmicb.2025.1580531
.avif)
.svg)
.svg)
